| Gender |
|
|
|
| No. of males |
|
30 |
| No. of females |
10 |
| Median age (range) |
66 (57–87) |
| Patients, treatment characteristics + Irradiation technique |
| Conventional RT |
15 |
| Hyper fractionated RT |
6 |
| Stereotactic body RT |
19 |
| Dose prescription |
|
|
| Conventional RT |
60–66 Gy/30-33 fr |
| Hyperfractionated RT |
45–54 Gy/30-36 fr |
| Stereotactic body RT |
52 Gy/4 fr |
| Median follow up period (range) |
18 months (6–48 months) |
| Radiation pneumonitis |
|
|
| Grade ≥2 |
|
10 (Conventional RT; 5, Hyperfractionated RT; 2, SBRT; 3) |
| Grade 1 |
|
30 (Conventional RT; 10, Hyperfractionated RT; 4, SBRT; 16) |
| Systemic therapy |
|
18 (Grade ≥2; 5, Grade1; 13) |
| Risk factor for pretherapeutic lung disease |
|
20 (Grade ≥2; 5, Grade 1; 15) |
| Infectious lung disease after therapy |
|
3 (Grade 1) |
